LDLR and hepatocellular carcinoma: Qin et al. found that upregulating LDLR expression in NK cells improved their ability to combat HCC by elevating intracellular cholesterol levels, suggesting that increasing cholesterol uptake in NK cells could be a promising therapeutic strategy for HCC 125.